CRP and Venous thrombosis: In addition, according to a meta-analysis of 75 studies with 17,052 hospitalized patients 18 years of age or older, the comparison between severe/non-survivors vs. non-severe/survivors and biomarkers of inflammation and/or thrombosis pointed out that except for D-dimer, fibrinogen and CRP, the following thromboinflammatory biomarkers—high-sensitivity CRP, ferritin, interleukin, and high-sensitivity troponin—also serve as markers of end-organ damage and are correlated with increased severity and mortality in COVID-19 patients [18].